Publications by authors named "N Mazanowska"
Article Synopsis
- The increasing accessibility of SMA treatments is leading more affected women to conceive, despite the associated risks of symptom progression during pregnancy.
- This paper discusses the case of a 21-year-old patient who received Nusinersen treatment during her third trimester, highlighting that she maintained her ability to walk even with disease progression.
- The study details both clinical outcomes, including positive postpartum motor function improvements, and economic considerations, noting no adverse effects on the patient or fetus.
We would like to express our sincere gratitude for your thoughtful review of our article [...
View Article and Find Full Text PDFHemolytic disease of the fetus and newborn (HDFN) is caused by maternal antibodies attacking fetal blood cell antigens. Despite routine antenatal anti-D prophylaxis, intrauterine transfusions (IUTs) are still needed in some HDFN cases. We conducted a retrospective cohort study on newborns with HDFN born in the 1st Department of Obstetrics and Gynecology of the Medical University of Warsaw.
View Article and Find Full Text PDF: One of the rare causes of cholestasis may be hemolytic disease of the fetus and newborn (HDFN). : We retrospectively analyzed 88 medical records of HDFN newborns with cholestasis and 186 records of children with HDFN without cholestasis and conducted an observational, case-control, retrospective study. : Factors influencing the risk of cholestasis were lower gestational age at birth (36.
View Article and Find Full Text PDFBackground: The number of women treated with immunosuppressants is increasing. Often, these women are of childbearing age. Consequently, they must face the decision of whether to breastfeed when they do have a child.
View Article and Find Full Text PDF